Epigenomics AG NA buy Quitte
Start price
05.11.15
/
50%
€2.75
Target price
13.01.16
€3.40
Performance (%)
60.61%
End price
13.01.16
€4.42
Summary
This prediction ended on 13.01.16 with a price of €4.42. With a performance of 60.61% the BUY prediction by Quitte was a big success. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Epigenomics AG NA | - | - | - | - |
| iShares Core DAX® | -0.552% | 3.405% | 17.621% | 18.214% |
| iShares Nasdaq 100 | -1.415% | 4.613% | 28.506% | 54.410% |
| iShares Nikkei 225® | -0.877% | -1.396% | 9.284% | 4.292% |
| iShares S&P 500 | -0.415% | 3.338% | 25.914% | 47.401% |
Comments by Quitte for this prediction
In the thread Epigenomics AG NA diskutieren
nur ein Aufschub
ich halte das für Spielchen, dass die FDA weitere Daten zum Zulassungsantrag will.
Epigenomics wird liefern
(Stop Loss Kurs erreicht)